XLXiaoping Li

Xiaoping Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaoping Li has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Tirzepatide attenuates doxorubicin-induced cardiotoxicity via mitochondrial function improvement

    by Zhong Li, Conghui Li, Han Zhan, Dingqin Cai, Yangyu Ou, Yan Long, Xiaoping Li, Limin Liu

    Background: Doxorubicin (DOX) can induce significant cardiotoxicity and compromise the safety of its clinical application. This study explored the cardioprotective potential of tirzepatide against DOX-induced cardiotoxicity. Methods: In this study, we employed both in vitro and in vivo DOX injury models to systematically assess cardiac function and myocardial tissue structure through echocardiography and histopathological analysis. Additionally, we examined mitochondrial ultrastructure using transmission electron microscopy (TEM) and evaluated mitochondrial membrane potential (MMP). Results: Our findings revealed that tirzepatide administration significantly enhanced cardiac systolic performance and reduced myocardial damage. Notably, tirzepatide effectively preserved mitochondrial function by maintaining cristae integrity and restoring MMP. Conclusions: These results demonstrate that tirzepatide confers protection against DOX-induced cardiotoxicity primarily through the amelioration of mitochondrial dysfunction.


  • Comprehensive scRNA-seq Model Reveals Artery Endothelial Cell Heterogeneity and Metabolic Preference in Human Vascular Disease

    by Liping Zeng, Yunchang Liu, Xiaoping Li, Xue Gong, Miao Tian, Peili Yang, Qi Cai, Gengze Wu, Chunyu Zeng

    Vascular disease is one of the major causes of death worldwide. Endothelial cells are important components of the vascular structure. A better understanding of the endothelial cell changes in the development of vascular disease may provide new targets for clinical treatment strategies. Single-cell RNA sequencing can serve as a powerful tool to explore transcription patterns, as well as cell type identity. Our current study is based on comprehensive scRNA-seq data of several types of human vascular disease datasets with deep-learning-based algorithm. A gene set scoring system, created based on cell clustering, may help to identify the relative stage of the development of vascular disease. Metabolic preference patterns were estimated using a graphic neural network model. Overall, our study may provide potential treatment targets for retaining normal endothelial function under pathological situations. Graphical abstract